Spots Global Cancer Trial Database for Stellate Ganglion Block for Major Depressive Disorder.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Stellate Ganglion Block for Major Depressive Disorder.
Official Title: Stellate Ganglion Block for Major Depressive Disorder: A Randomized Controlled Pilot Trial
Study ID: NCT04727229
Study Description
Brief Summary: This is a feasibility study, to investigate a new treatment option for major depressive disorders by performing a Stellate Ganglion Block (SGB). A SGB is an injection of local anesthetic into the sympathetic nervous system (peripheral nervous system) located in the lower part of the neck, to relieve pain in the head, neck, upper arm, and upper chest.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
St. Michael's Hospital, Toronto, Ontario, Canada
Contact Details
Name: Karim Ladha, MD
Affiliation: Unity Health Toronto
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
